Cite

HARVARD Citation

    Giuliani, J. et al. (n.d.). 537PThe financial toxicity of non-small lung cancer treatment: The optimization of first and second-line therapy with immune check point inhibitors. Annals of oncology. p. . [Online]. 
  
Back to record